Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/300016 stock hub

SHE/300016 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300016is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.4B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300016

In the news

Latest news · SHE/300016

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E41.5

P25 23.5P50 41.3P75 83.2

ROE5.6

P25 -0.9P50 4.1P75 8.8

ROIC4

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300016 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

235

Groups with data

Currency

CNY

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,173
Employees Change	221%
Employees Change Percent	23.21
Enterprise value	CNY 5.3B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE000001QK9
Last refreshed	2026-05-10
Market cap	CNY 5.4B
Price	CNY 9.57
Price currency	CNY
Rev Per Employee	1,059,646.1x
Sector	Healthcare
Sic	2834
Symbol	she/300016
Website	https://www.beilu.com.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.29%
EV Earnings	43.01x
EV/EBIT	43.05x
EV/EBITDA	23.75x
EV/FCF	1,641.39x
EV/Sales	4.26x
FCF yield	0.06%
P/B ratio	2.19x
P/E ratio	41.54x
P/S ratio	4.33x
PE Ratio10 Y	92.08x
PE Ratio5 Y	108.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.75%
EBITDA Margin	16.46%
FCF margin	0.26%
Gross margin	45.34%
Gross Profit	CNY 563.5M
Gross Profit Growth	19.37%
Gross Profit Growth Q	15.99%
Gross Profit Growth3 Y	14.12%
Gross Profit Growth5 Y	-1.3%
Net Income	CNY 123.2M
Net Income Growth	639.15%
Net Income Growth Q	209.36%
Net Income Growth Quarters	8%
Net Income Growth Years	2%
Net Income Growth5 Y	-9.09%
Pretax Margin	11.87%
Profit Margin	9.91%
Profit Per Employee	CNY 105,006
Profitable Years	2
ROA	2.05
Roa5y	1
ROCE	3.84
ROE	5.64
Roe5y	1
ROIC	4.01
Roic5y	2.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-2.95%
Cagr15y	6.93%
Cagr1y	45.24%
Cagr3y	12.46%
Cagr5y	1.15%
Div CAGR10	2.26%
Div CAGR3	-10.61%
Div CAGR5	-6.51%
EPS Growth	527.2
EPS Growth Q	170.3
EPS Growth Quarters	8
EPS Growth Years	2
EPS Growth5 Y	-10.9
FCF Growth	-93.28%
FCF Growth Q	1,821.12%
FCF Growth3 Y	-53.46%
OCF Growth	35.33%
OCF Growth Q	171.89%
OCF Growth10 Y	8.16%
OCF Growth3 Y	17.85%
OCF Growth5 Y	6.67%
Revenue Growth	17.4x
Revenue Growth Q	13.33x
Revenue Growth Quarters	15x
Revenue Growth Years	3x
Revenue Growth3 Y	17.31x
Revenue Growth5 Y	6.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.37
Assets	CNY 3.4B
Cash	CNY 800.4M
Current Assets	CNY 1.4B
Current Liabilities	CNY 604.9M
Debt	CNY 551.2M
Debt EBITDA	CNY 2.68
Debt Equity	CNY 0.22
Debt FCF	CNY 171
Equity	CNY 2.5B
Interest Coverage	3.88
Liabilities	CNY 975M
Long Term Assets	CNY 2B
Long Term Liabilities	CNY 370.1M
Net Cash	CNY 249.2M
Net Cash By Market Cap	CNY 4.63
Net Debt EBITDA	CNY -1.22
Net Debt Equity	CNY -0.1
Net Debt FCF	CNY -77.21
Tangible Book Value	CNY 2.1B
Tangible Book Value Per Share	CNY 3.76
WACC	6.1

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.39
Inventory Turnover	1.91
Net Working Capital	CNY 325.3M
Quick ratio	1.72
Working Capital	CNY 842.1M
Working Capital Turnover	CNY 1.47

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-17.86%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CNY 0.05
Dividend Years	1
Dividend Yield	0.52%
Last Dividend	CNY 0.05
Payout Ratio	31.34%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-25.84%
1Y total return	45.2%
200-day SMA	9.34
3Y total return	42.23%
50-day SMA	10.06
50-day SMA vs 200-day SMA	50over200
5Y total return	5.9%
All Time High	44.39
All Time High Change	-78.44%
All Time High Date	2015-06-02
All Time Low	2.57
All Time Low Change	272.81%
All Time Low Date	2012-01-06
ATR	0.37
Beta	0.37
Beta1y	0.33
Beta2y	0.61
Ch YTD	20.53
High	9.7
High52	11.98
High52 Date	2025-08-19
High52ch	-20.12%
Low	9.51
Low52	6.51
Low52 Date	2025-05-29
Low52ch	47.01%
Ma50ch	-4.83%
Price vs 200-day SMA	2.45%
RSI	45.43
RSI Monthly	58.81
RSI Weekly	51.33
Sharpe ratio	1x
Sortino ratio	1.85
Total Return	-17.34%
Tr YTD	20.53
Tr15y	173.2%
Tr1m	-5.53%
Tr1w	-0.93%
Tr3m	-3.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 108.7M
Operating Income Growth	115.2
Operating Income Growth Q	70.69
Operating Income Growth5 Y	-8.12
Operating margin	8.75

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	427,831,580%
Net Borrowing	-16,271,684
Shares Insiders	15.2%
Shares Institutions	2.07%
Shares Out	562,873,163
Shares Qo Q	4.61%
Shares Yo Y	17.86%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 3.2M
Average Volume	23,675,546.2x
Bv Per Share	4.1
CAPEX	CNY -229.6M
Ch10y	-29.87
Ch15y	146.4
Ch1m	-5.53
Ch1w	-0.93
Ch1y	44.13
Ch3m	-3.43
Ch3y	39.71
Ch5y	2.9
Ch6m	11.8
Change	-1.14%
Change From Open	-0.83
Close	9.68
Days Gap	-0.31
Depreciation Amortization	95,805,287
Dollar Volume	169,161,530.7
Earnings Date	2026-04-22
EBIT	CNY 108.7M
EBITDA	CNY 204.5M
EPS	CNY 0.23
F Score	7
FCF	CNY 3.2M
FCF EV Yield	0.06x
FCF Per Share	CNY 0.01
Financing CF	-57,724,645
Fiscal Year End	December
Founded	1,992
Goodwill	46,924,655
Graham Number	4.60964
Graham Upside	-51.83
Income Tax	CNY 26.1M
Investing CF	-355,860,066
Is Primary Listing	1
Last Earnings Date	2026-04-22
Last Report Date	2026-03-31
Last Split Date	2018-09-04
Last Split Type	Forward
Lynch Fair Value	CNY 1.15
Lynch Upside	-87.96
Ma150	9.23
Ma150ch	3.73%
Ma20	9.86
Ma20ch	-2.92%
Net CF	-184,114,837
Next Earnings Date	2026-08-27
Open	9.65
P FCF Ratio	1,669
P OCF Ratio	23.13
Payment Date	2025-05-19
Position In Range	31.58
Ppne	1,134,283,521
Price Date	2026-05-08
Price EBITDA	CNY 26.34
Ptbv Ratio	2.55
Relative Volume	0.74x
Revenue	1,242,964,871x
Tax By Revenue	2.1x
Tax Rate	17.67%
Tr6m	11.8%
Volume	17,676,231

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300016 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.5%

$0.05 annual per share

Payout ratio

+31.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-6.5%

0 consecutive years of growth

Total shareholder yield

-17.3%

Dividend yield + buyback yield combined

Performance

SHE/300016 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300016?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.1%

Share of float held by funds and institutions

Insider ownership

+15.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+17.9%

Negative means the company is buying back shares.

Technical

SHE/300016 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.4

Neutral momentum band

Price vs 200-day MA

+2.5%

50/200-day relationship not available

Beta (5Y)

0.37

Less volatile than the market

Sharpe ratio

1.00

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300016

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300016 stock rating?

she/300016 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300016 analysis?

The full report lives at /stocks/she/300016/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300016?

The latest report frames she/300016 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300016 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.